Monday, November 04, 2019 6:19:50 AM
Execution of financials and general business it is a dud .
Science it is Nobel worthy .
Time , the devices have taken time to configure + the criteria for being a patient are detailed which also causes delay . Not making excuses think there is more going on as well .
Time B . We are close to having 3 month results of 10 patients , guess , by June of 2020 .
Risk/Reward the big tell at this time . $5000 gets 20 to 25 thous shares . If there is a glitch the stock could go to .08 and you lose 2500 .
If 10 are clean $25 is doable and 500 thous to the lucky buyer .
From Phase 1 these results are probable .
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM